| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 25 |
| 1 | PREDNISONE | 18 |
| 2 | ACETAMINOPHEN 500MG | 17 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 17 |
| 4 | CYCLOPHOSPHAMIDE | 17 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 17 |
| 8 | PAIN RELIEVER | 17 |
| 9 | FLUDARABINE PHOSPHATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REZAFUNGIN | 1 | 0.0099 |
| 1 | ELAPEGADEMASE-LVLR | 1 | 0.0033 |
| 2 | RILZABRUTINIB | 1 | 0.0018 |
| 3 | L-LYSINE | 1 | 0.0014 |
| 4 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 1 | 0.0013 |
| 5 | TRIMIPRAMINE | 1 | 0.0009 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| 7 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| 8 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 9 | AZATHIOPRINE SODIUM | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 22 |
| 3 | Alkylating Drug [EPC] | 17 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 5 | Benzodiazepine [EPC] | 13 |
| 6 | Catecholamine [EPC] | 13 |
| 7 | alpha-Adrenergic Agonist [EPC] | 13 |
| 8 | beta-Adrenergic Agonist [EPC] | 13 |
| 9 | Expectorant [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 3 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 3 | 0.0002 |
| 4 | Catecholamine [EPC] | 13 | 0.0002 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 12 | 0.0001 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 8 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 9 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |